首页>
外国专利>
METHOD FOR DETERMINING APPLICATION OF NOVEL THERAPY TO MULTIPLE SCLEROSIS (MS) PATIENT
METHOD FOR DETERMINING APPLICATION OF NOVEL THERAPY TO MULTIPLE SCLEROSIS (MS) PATIENT
展开▼
机译:确定新型疗法在多发性硬化症(MS)患者中的应用的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
According to the present invention, the therapeutic effect of an IL-6 inhibitor on MS was found to be predictable by using as indicators the amount of plasmablasts and/or the indicator of change in immature plasmablasts (amount of immature plasmablasts or amount of follicular helper T cells) in MS patients with a large amount of plasmablasts. Furthermore, IL-6 inhibitors were found to be effective against MS in which plasmablasts occur at high levels and in which the indicator of change in immature plasmablasts is high. The present invention provides methods for selecting MS cases for which treatment with an IL-6 inhibitor is effective, and also provides an effective therapeutic method for patients with MS in which plasmablast occur at high levels and in which the indicator of change in immature plasmablasts is high.
展开▼